SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant investor alarm following the arrest of a co-founder and two associates for allegedly smuggling high-performance hardware to China, fueling concerns about governance, future partnership stability, and potential regulatory repercussions. The community is actively debating whether the company is a victim of rogue insider activity or if the pattern of leadership and compliance failures makes the stock fundamentally uninvestable.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant downward pressure as market sentiment sours amid an expanded NHTSA investigation into its self-driving software and concerns over weakening EV sales. Investors are actively debating the stock's long-term valuation, with many traders pivoting to short-term put positions while community discourse remains deeply polarized between long-term bulls and those citing structural headwinds as evidence of a looming correction.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The S&P 500 is currently trending as investors navigate a volatile mix of geopolitical instability in the Middle East and upcoming quad-witching volatility. The community is sharply divided, with active debates centered on whether recent market moves are a temporary relief rally or an inevitable precursor to a larger correction, while many monitor energy prices and potential military escalations for clues on future market direction.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing heightened volatility as investors grapple with conflicting reports regarding geopolitical tensions in the Middle East, specifically concerning Iranian energy infrastructure and the stability of the Strait of Hormuz. Market participants are actively debating whether these developments signal an imminent global energy crisis or if recent price fluctuations reflect a temporary reaction to diplomatic messaging and war-funding debates.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently in the spotlight as investors react to a mix of new product launches and shifting delivery targets for 2026, alongside ongoing discussions about the company's aggressive global expansion and potential for commercializing humanoid robotics. The community is actively debating the stock's valuation versus regional peers, with strong focus on how recent management-led initiatives and upcoming quarterly results may impact momentum.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending as investors react to strong earnings results, highlighted by record annual revenue and a significant expansion in defense sector backlog. Community discussion remains focused on the company's dual role in government defense infrastructure and AI-driven satellite imagery, with many comparing its growth trajectory to other major players in the emerging space economy.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure and community frustration as the stock struggles to maintain momentum, frequently decoupling from broader market rallies. Investors are actively discussing the company's heavy AI-related capital expenditures and potential legal disputes, with many expressing concern over persistent underperformance compared to other tech sector leaders.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic is seeing significant positive sentiment and accumulation, driven by rising fertilizer demand, strong agricultural fundamentals, and the expectation that recent cost-cutting measures and strategic divestitures will boost long-term profitability. Investors are actively discussing the stock's potential for a valuation re-rating as they monitor upcoming earnings for confirmation of margin expansion and growth momentum.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is currently seeing heightened volatility and investor attention as the drone manufacturing sector faces intense focus regarding the U.S. government's 'Drone Dominance' program and the push for domestic supply chains. The community is sharply divided, with bulls pointing to the company's manufacturing ramp-up, insider connections, and potential contract wins, while bears express significant concern over persistent share dilution, high volatility, and skepticism surrounding the firm's path to profitability.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is facing intense selling pressure and volatility, driven by a reverse stock split and alarming allegations surrounding the underlying SMCI stock. Investors are heavily divided, with some viewing the massive price drop as a contrarian buying opportunity while others express frustration over severe portfolio losses and the rapid decay inherent in the leveraged ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fulcrum Therapeutics Touts PIONEER HbF Gains, Early VOC Signal; FDA Path and Accelerated Approval Talk

Fulcrum Therapeutics (NASDAQ:FULC) executives highlighted what they described as strong physician interest and encouraging clinical signals from the company's PIONEER study in sickle cell disease...

Short Interest in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Rises By 19.7%

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 27th, there was short interest totaling...

Fulcrum Therapeutics, Inc. $FULC Shares Bought by Boothbay Fund Management LLC

Boothbay Fund Management LLC raised its holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Free Report) by 104.2% during the third quarter, according to its most recent disclosure with the...

219,488 Shares in Fulcrum Therapeutics, Inc. $FULC Bought by Braidwell LP

Braidwell LP acquired a new stake in Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 219,488...

Fulcrum Therapeutics (NASDAQ:FULC) Stock Price Down 7.5% - Here's Why

Fulcrum Therapeutics (NASDAQ:FULC) Shares Down 7.5% - Here's Why...

HC Wainwright Has Optimistic Outlook of FULC Q1 Earnings

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Free Report) - Stock analysts at HC Wainwright lifted their Q1 2026 earnings per share (EPS) estimates for shares of Fulcrum Therapeutics in a report issued...

Equities Analysts Issue Forecasts for FULC FY2030 Earnings

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Free Report) - Equities research analysts at HC Wainwright issued their FY2030 earnings estimates for Fulcrum Therapeutics in a note issued to investors on...

Fulcrum Therapeutics (NASDAQ:FULC) Shares Gap Down - What's Next?

Fulcrum Therapeutics (NASDAQ:FULC) Shares Gap Down - What's Next...

Fulcrum Therapeutics Q4 Earnings Call Highlights

Fulcrum Therapeutics (NASDAQ:FULC) shared full 12-week results from the 20-mg cohort of its phase 1b PIONEER trial evaluating pociredir in patients with sickle cell disease, expanding on partial data...

Fulcrum Therapeutics (NASDAQ:FULC) Releases Quarterly Earnings Results, Meets Expectations

Fulcrum Therapeutics (NASDAQ:FULC - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.31) earnings per share (EPS) for the quarter, meeting the consensus...

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

FULC
Fulcrum Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FULC News

FULCFulcrum Therapeutics Inc